Status:
COMPLETED
Impact of Lung Cancer Diagnosis on Relatives' Understanding of Genetic Risk and Receptivity to Quit Smoking
Lead Sponsor:
National Human Genome Research Institute (NHGRI)
Conditions:
Lung Cancer
Eligibility:
All Genders
18-55 years
Brief Summary
This study will explore beliefs and knowledge about genetics and smoking among smokers who have a first or second degree relative with advanced lung cancer, and whether their understanding of genetic ...
Detailed Description
The overarching objective of this observational prospective "Genetic Risk \& Lung Cancer Study" is to evaluate the impact of a loved one's lung cancer diagnosis on relative's seeking and processing of...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- The target sample for the study is healthy adult smokers ages 18 to 55 who are first or second degree blood relatives (e.g., siblings, sons, daughters, grandsons, granddaughters, nieces, nephews, grandnieces, grandnephews) of a late stage lung cancer patient (Stage IIIB or IV) who is receiving care at MCC.
- Aside from age and blood relationship to the lung cancer patient, eligibility criteria also will include the following:
- No current or previous diagnosis of cancer;
- Has access and some willingness to use the internet;
- Is willing to be contacted by NIH study staff;
- Has a score lower than 14 on the Centers for Epidemiological Survey of Depression (CESD);
- Is English speaking.
Exclusion
Key Trial Info
Start Date :
December 7 2004
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 16 2010
Estimated Enrollment :
757 Patients enrolled
Trial Details
Trial ID
NCT00341341
Start Date
December 7 2004
End Date
July 16 2010
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892